Bayer

JIVI

Manufacturer:

Bayer

Jivi HCPCS:

J7208

HCPCS Code Descriptor:

Injection, factor viii, (antihemophilic factor, recombinant), pegylated-aucl, (jivi), 1 i.u.

Category:

J Code

Jivi NDCs:

00026-3948-25, 00026-3944-25, 00026-3946-25, 00026-3942-25

Primary Type:

Hematology

Generic/Specialty Status:

Single-Source

Package Type:

Vial

Route of Administration:

Intravenous

Jivi CPT Codes:

Potential CPT administration codes for Jivi can be found at the following link.

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Jivi:

JIVI is a Hematology drug manufactured by Bayer and administered via the Intravenous route of administration. The J Code: J7208 is aligned to the drug JIVI.

JIVI is used to control the bleeding in patients with a certain blood disorder. This medication is an artificial form of factor VIII, which helps thicken and clot the blood. JIVI is manufactured by Bayer pharmaceuticals. This drug has been aligned to the HCPS code J7208 and has been since July 1st, 2019, and is still currently aligned to this code. Before J7208, JIVI was aligned to the HCPCS code C9141 from April 1st, 2019, to June 30th, 2019. Patient assistance programs for this medication can be found through the Bayer US Assistance Foundation.

ACCESS PRICING AND MORE BY REGISTERING

J7208 Added Date:

July 1, 2019

J7208 Effective Date:

July 1, 2019

J7208 Termination Date:

HCPCS Active

Jivi billing and coding information can be found through Bayer at the link below:
Jivi patient assistance information can be found through Bayer Patient Assistance at the URL: https://www.patientassistance.bayer.us/
JIVI prescribing information can be found at the link below:
Our team has not yet identified a source of side effects information for JIVI. Please check back in a few weeks.